Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
π Zimmer Biomet Holdings, Inc. (NYSE/SIX: ZBH) announced on May 22, 2026, that its Board of Directors approved a quarterly cash dividend for the second quarter of 2026.
π° The approved dividend amount is $0.24 per share to be paid to stockholders.
π The dividend payment date is scheduled for approximately July 31, 2026.
π Stockholders must be on record as of the close of business on June 25, 2026, to receive the payment.
π’ Zimmer Biomet describes itself as a global medical technology leader with a comprehensive portfolio focused on mobility and health improvement.
π€ The company leverages data analytics and artificial intelligence through its integrated digital and robotic technologies.
π Zimmer Biomet operates in 25+ countries and generates sales in over 100 countries globally.
π The company highlights its legacy of 90+ years of trusted leadership and expertise in the medical technology sector.
π Investors can find more information about the product portfolio and operations at www.zimmerbiomet.com.
- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) announced a quarterly cash dividend of $0.24 per share for the second quarter of 2026, payable on or about July 31, 2026.
- The company is recognized as a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.
- Zimmer Biomet leverages innovative products and integrated digital and robotic technologies that utilize data analytics and artificial intelligence to transform the patient experience.
- With over 90 years of trusted leadership, the company is positioned to deliver high-quality solutions to patients and providers worldwide.
- The company operates in 25+ countries with sales reaching 100+ countries, demonstrating a strong global footprint.
- The article contains no negative aspects or risks for Zimmer Biomet Holdings, Inc. (ZBH); it solely reports a positive dividend announcement and corporate growth metrics.